Godrej Agrovet reported a 10% consolidated revenue growth for Q1 FY27, reaching ₹2,852 crore. Growth was driven by strong performance in Animal Nutrition and Oil Palm segments, offsetting a decline in Crop Care due to delayed monsoons. The company is strategically shifting its food business towards B2C products.
Godrej Agrovet Q1 FY27 Results
Consolidated Sales: ₹2,852 crore (10% YoY Growth)
Animal Nutrition Revenue: ₹1,500 crore (12.6% YoY Growth)
Reader Takeaway: Diversified growth buffers segment weakness; monsoon, inflation are key watch points.
What just happened
Godrej Agrovet announced its Q1 FY27 financial results, showing a 10% year-on-year increase in consolidated revenue to ₹2,852 crore. The company navigated challenges like erratic weather and inflation, with key business segments showing varied performance.
Why this matters
The results demonstrate the company's resilience through a diversified portfolio. While strong performance in Animal Nutrition and Oil Palm contributed positively, the Crop Care segment faced headwinds. The strategic shift towards B2C food products and the turnaround at Astec LifeSciences are key developments for future growth.
The backstory
Godrej Agrovet operates across several verticals including animal feed, crop protection chemicals, oil palm plantations, and dairy. The company has been focusing on expanding its presence in high-growth areas and improving operational efficiencies. Recent quarters have seen varied performance across segments, influenced by agricultural cycles and commodity prices.
What changes now
The company plans to continue its focus on its B2C food business and dairy transformation. Capital expenditure of ₹300-350 crore is planned for the year, mainly for integrated palm oil complexes and specialty fats. Management aims for double-digit consolidated revenue growth for the full year.
Risks to watch
The Crop Care segment's performance remains sensitive to monsoon patterns. The company also faces ongoing pressure from input inflation, particularly in milk procurement and packaging, impacting the dairy business. These factors are expected to persist for the next few quarters.
Peer comparison
Companies in the agri-input sector often face similar weather-related risks. However, Godrej Agrovet's diversification into animal nutrition and oil palm provides a more stable revenue stream compared to pure-play crop protection companies. Competitors in the food processing segment will be watching Godrej's B2C strategy closely.
Context metrics (time-bound)
- Animal Nutrition Revenue grew 12.6% YoY.
- Cattle Feed Volume increased by 15%.
- Oil Palm Revenue rose 28.9% YoY.
- Crop Care Revenue declined 16.2% YoY.
- Astec LifeSciences achieved EBITDA breakeven, a turnaround from a ₹11 crore loss in Q1 FY26.
What to track next
Investors will be closely watching the impact of rainfall on the Crop Care segment through September. The company's ability to manage inflationary pressures in its dairy business and the progress of its B2C food strategy will also be key indicators.